Latest Acquisition News

Seven West Media shareholders have overwhelmingly approved the proposed acquisition by Southern Cross Media Group, clearing a major hurdle ahead of final court approval.

Little Green Pharma welcomes a landmark US Executive Order directing cannabis rescheduling, a move poised to reshape the global medicinal cannabis landscape.

Gratifii Limited is set to transform its digital marketing and engagement capabilities through the acquisition of New Zealand’s Mosh Digital and the Future Pass digital wallet platform, backed by a $2.5 million capital raise.

Silver Mines Limited reports promising results from a recent drilling program at its Tuena Project, revealing significant gold and base metal mineralisation along a key fault corridor in New South Wales.

Seven West Media shareholders convened on 22 December 2025 to vote on a landmark acquisition by Southern Cross Media Group, potentially reshaping Australia's media landscape. The proposed scheme promises a combined media powerhouse spanning television, digital, audio, and publishing.

African Gold Limited has reported significant step-out drilling results at its Blaffo Guetto deposit in Côte d’Ivoire, extending gold mineralisation beyond previous estimates and reinforcing the project’s scale and potential under new Montage Gold ownership.

Finbar Group has conditionally acquired a prime South Perth site for $16.5 million, aiming to launch a $350 million apartment development by 2028 and boosting its pipeline to over $1.6 billion.

Midas Minerals has completed its acquisition of the Otavi Copper Project in Namibia, initiating multiple drilling programs across high-grade deposits and securing strong funding to drive exploration in 2026.

Comet Ridge Limited has obtained federal environmental approval for its Mahalo North natural gas project, paving the way for expanded development in Queensland’s Bowen Basin. This milestone complements recent ownership consolidation and state approvals, positioning the company to boost east coast gas supply.

BioMarin Pharmaceutical’s acquisition of Amicus Therapeutics for US$4.8 billion includes Dimerix’s US licensing agreement, promising significant milestone payments and royalties. This deal strengthens Dimerix’s position as it advances its Phase 3 kidney disease therapy.

IVE Group has agreed to acquire Australian creative agency Daily Press for up to $35 million, bolstering its digital, social, and performance marketing capabilities as part of its ‘Now to 2030’ growth strategy.

Mayne Pharma reports mixed early FY26 results with strong prescription growth in Women’s Health and improved Dermatology margins, while strategic reviews and litigation loom.